Michael W. Dunne Insider Trading $ITRM Iterum Therapeutics plc

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Michael W. Dunne.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Michael W. Dunne. Michael W. Dunne is Director in Aviragen Therapeutics, Inc. ($NABI) and Chief Medical Officer in Durata Therapeutics, Inc. ($DRTX) and Chief Scientific Officer in Iterum Therapeutics plc ($ITRM) and Director in Iterum Therapeutics plc ($ITRM).

Michael W. Dunne in Iterum Therapeutics plc

Trading Symbol: ITRM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael W. Dunne: Director, Chief Scientific Officer
Holdings: 289,498 shares
Latest Transaction: Mar 29 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Michael W. Dunne in Iterum Therapeutics plc

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, DRTX, ITRM, VXRT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 29 2021ITRMIterum Therapeutic ...Dunne Michael W.DirectorOption ExerciseA0.0010,494010,494
Jan 27 2021ITRMIterum Therapeutic ...Dunne Michael W.DirectorSellS1.7333,14357,337256,355289.5 K to 256.4 K (-11.45 %)
Jan 27 2021ITRMIterum Therapeutic ...Dunne Michael W.DirectorGrantA0.0080,0000289,498209.5 K to 289.5 K (+38.19 %)
Oct 28 2020ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...Option ExerciseP0.6546,15530,00146,155
Oct 28 2020ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...BuyP0.0061,5400209,498148 K to 209.5 K (+41.59 %)
Feb 19 2019ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...Option ExerciseA5.8085,000493,00085,000
Sep 06 2018ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...BuyP10.005005,000147,958147.5 K to 148 K (+0.34 %)
Aug 28 2018ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...BuyP10.005005,000147,458147 K to 147.5 K (+0.34 %)
Aug 28 2018ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...BuyP10.005005,000146,958146.5 K to 147 K (+0.34 %)
May 30 2018ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...Option ExerciseC0.002,91700
May 30 2018ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...Option ExerciseC0.004,05000
May 30 2018ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...Option ExerciseC0.0012,73000
May 30 2018ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...BuyP13.002,00026,000146,458144.5 K to 146.5 K (+1.38 %)
May 30 2018ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...BuyC0.002,9170144,458141.5 K to 144.5 K (+2.06 %)
May 30 2018ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...BuyC0.004,0500141,541137.5 K to 141.5 K (+2.95 %)
May 30 2018ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...BuyC0.0012,7300137,491124.8 K to 137.5 K (+10.20 %)
May 29 2018ITRMIterum Therapeutic ...Dunne Michael W.Chief Scientific Of ...Option ExerciseA13.0079,5671,034,37179,567

Page:   1